tiprankstipranks
Trending News
More News >
Brainhole Technology Limited (HK:2203)
:2203
Hong Kong Market

Brainhole Technology Limited (2203) AI Stock Analysis

Compare
1 Followers

Top Page

HK:2203

Brainhole Technology Limited

(2203)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 4o)
Rating:42Neutral
Price Target:
HK$0.18
▼(-17.27% Downside)
The overall stock score of 42 reflects significant financial challenges, including negative profitability and high leverage. Technical indicators suggest weak momentum, and valuation metrics highlight poor attractiveness due to negative earnings. The lack of earnings call data and corporate events further limits positive factors.
Positive Factors
Innovative Product Development
Brainhole Technology's commitment to innovation positions it well for long-term growth, as it can adapt to market demands and create new revenue streams.
Diversified Revenue Model
A diversified revenue model reduces dependency on any single income source, enhancing financial stability and resilience against market fluctuations.
Strategic Partnerships
Strategic partnerships can expand market reach and distribution capabilities, providing a competitive edge and supporting sustainable revenue growth.
Negative Factors
Declining Revenue
Declining revenues indicate potential market share loss and reduced demand, challenging the company's ability to sustain operations and invest in growth.
High Leverage
High leverage limits financial flexibility and increases risk, as the company may struggle to meet debt obligations during downturns.
Negative Cash Flow
Negative cash flow suggests operational inefficiencies and challenges in generating sufficient cash to fund operations, impacting long-term viability.

Brainhole Technology Limited (2203) vs. iShares MSCI Hong Kong ETF (EWH)

Brainhole Technology Limited Business Overview & Revenue Model

Company DescriptionBrainhole Technology Limited (2203) is a forward-thinking company specializing in the development and implementation of advanced artificial intelligence solutions and data analytics services. Operating primarily within the tech sector, the company focuses on creating cutting-edge software applications designed to enhance decision-making processes across various industries, including finance, healthcare, and logistics. With a commitment to innovation, Brainhole Technology provides a suite of products that leverage machine learning and big data analytics to deliver actionable insights and optimize operational efficiency for its clients.
How the Company Makes MoneyBrainhole Technology Limited generates revenue through multiple key streams, primarily focusing on the sales of its proprietary software solutions and data analytics services. The company employs a subscription-based model for its software products, allowing clients to access continuous updates and support for a recurring fee. Additionally, Brainhole Technology engages in consulting services that assist businesses in integrating AI-driven solutions into their existing systems, which further contributes to its revenue. Strategic partnerships with cloud service providers and enterprise software firms enhance its market reach and provide bundled offerings that attract a wider clientele. Furthermore, the company may also earn revenue through licensing agreements for its technology and intellectual property, ensuring a diversified income portfolio.

Brainhole Technology Limited Financial Statement Overview

Summary
Brainhole Technology Limited is facing significant financial challenges with declining revenues, negative profitability margins, and high leverage. The company's financial health is concerning, with negative cash flows and a high debt-to-equity ratio, indicating potential liquidity and solvency risks.
Income Statement
15
Very Negative
The company has been experiencing declining revenues with a negative revenue growth rate of -14.79% TTM. Gross profit margin is negative at -9.31%, indicating costs exceed revenues. Net profit margin is significantly negative at -163.65%, reflecting substantial losses. EBIT and EBITDA margins are also deeply negative, showing operational inefficiencies.
Balance Sheet
25
Negative
The debt-to-equity ratio is high at 2.28 TTM, indicating significant leverage and potential financial risk. Return on equity is positive at 9.36% TTM, which is unusual given the negative net income, suggesting potential accounting anomalies. The equity ratio is low, indicating a reliance on debt financing.
Cash Flow
20
Very Negative
Operating cash flow is negative, indicating cash outflows from operations. Free cash flow is also negative, with a growth rate of -19.71% TTM, suggesting deteriorating cash generation. The operating cash flow to net income ratio is negative, highlighting cash flow challenges.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue89.08M119.99M220.81M263.57M321.57M261.81M
Gross Profit-8.30M-6.45M27.63M48.54M54.11M33.52M
EBITDA-74.86M-88.09M-18.99M-34.46M-19.62M-37.50M
Net Income-145.78M-127.88M-34.12M-57.61M-51.55M-58.76M
Balance Sheet
Total Assets135.27M152.74M279.20M333.42M353.63M370.34M
Cash, Cash Equivalents and Short-Term Investments76.59M74.80M111.75M107.92M42.64M74.15M
Total Debt63.70M163.71M138.78M147.44M84.93M113.13M
Total Liabilities107.35M211.81M212.43M231.84M211.31M183.70M
Stockholders Equity27.92M-59.07M66.76M101.58M142.32M186.64M
Cash Flow
Free Cash Flow-27.44M-39.49M27.21M-113.92M-4.96M-18.72M
Operating Cash Flow-27.13M-38.96M32.19M-106.08M-535.00K-4.92M
Investing Cash Flow18.27M4.23M6.00M11.45M1.48M-55.08M
Financing Cash Flow-15.14M19.45M-20.10M76.53M-31.00M80.58M

Brainhole Technology Limited Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.22
Price Trends
50DMA
0.21
Positive
100DMA
0.21
Positive
200DMA
0.20
Positive
Market Momentum
MACD
<0.01
Negative
RSI
55.22
Neutral
STOCH
64.70
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:2203, the sentiment is Positive. The current price of 0.22 is above the 20-day moving average (MA) of 0.20, above the 50-day MA of 0.21, and above the 200-day MA of 0.20, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 55.22 is Neutral, neither overbought nor oversold. The STOCH value of 64.70 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for HK:2203.

Brainhole Technology Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
59
Neutral
HK$126.00M-15.29-2.32%-6.45%-596.43%
59
Neutral
HK$234.00M27.983.83%-13.07%-34.88%
43
Neutral
HK$98.83M-0.87
42
Neutral
HK$192.80M-1.20-47.92%-869.15%
41
Neutral
HK$81.13M-1.07-41.46%-26.02%-4977.27%
39
Underperform
HK$100.35M-0.7637.63%56.51%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
HK:2203
Brainhole Technology Limited
0.22
0.00
0.00%
HK:1679
Risecomm Group Holdings Limited
0.46
0.02
4.55%
HK:1912
Contel Technology Company Limited
0.72
-0.70
-49.30%
HK:1967
Confidence Intelligence Holdings Limited
0.42
0.06
16.67%
HK:8257
Genes Tech Group Holdings Company Limited
0.24
0.15
166.67%
HK:8490
Niche-Tech Semiconductor Materials Limited
0.12
-0.06
-34.29%

Brainhole Technology Limited Corporate Events

Brainhole Technology Announces Strategic Securities Transactions
Nov 18, 2025

Brainhole Technology Limited has announced two significant financial transactions involving the acquisition and disposal of listed securities. The company acquired 34,300 shares of Canadian Solar for approximately US$1.0 million, funded by the proceeds from the disposal of 11,300 Robinhood shares for about US$1.3 million. These transactions are classified as discloseable under the Hong Kong Stock Exchange Listing Rules, impacting the company’s financial strategy and market positioning.

Brainhole Technology Granted Waiver for Circular Dispatch Delay
Nov 13, 2025

Brainhole Technology Limited has been granted a waiver from strict compliance with Rule 14.41(a) of the Listing Rules by the Hong Kong Stock Exchange, allowing for a delay in the dispatch of a circular related to its further acquisition of TeraWulf shares. The waiver permits the company to send out the circular by December 23, 2025, providing additional time to finalize necessary financial information and disclosures, which may impact the company’s transaction timeline and stakeholder communications.

Brainhole Technology Limited Engages in Strategic Securities Transactions
Nov 3, 2025

Brainhole Technology Limited announced the further acquisition of 14,700 Nebius shares for approximately US$1.9 million and the disposal of 126,000 TeraWulf shares for the same amount. These transactions are considered discloseable under Hong Kong’s Listing Rules, impacting the company’s investment portfolio and market positioning in the technology sector.

Brainhole Technology Limited Announces Disposal of Nebius Shares
Oct 30, 2025

Brainhole Technology Limited has announced the disposal of 15,300 shares of Nebius, a technology company based in the Netherlands that specializes in AI infrastructure, through an open market transaction. This disposal, valued at approximately US $1.9 million, is expected to result in a gain of about US $0.8 million for Brainhole Technology Limited. The transaction is classified as a discloseable transaction under the Listing Rules, which may impact the company’s financial standing and market perception.

Brainhole Technology Granted Waiver for Circular Dispatch Delay
Oct 24, 2025

Brainhole Technology Limited, a company incorporated in the Cayman Islands, announced a delay in the dispatch of a circular related to the further disposal of Robinhood shares, which is a major transaction under Chapter 14 of the Listing Rules. The company has been granted a waiver from strict compliance with Rule 14.41(a) by the Stock Exchange, allowing them to dispatch the circular by November 21, 2025, due to the need for additional time to finalize financial information.

Brainhole Technology Expands Investment in TeraWulf
Oct 12, 2025

Brainhole Technology Limited has announced a further acquisition of 100,800 TeraWulf shares for approximately US$1.5 million. This acquisition, combined with previous purchases, totals approximately US$2.8 million, making it a discloseable transaction under Hong Kong’s Listing Rules. The acquisition was financed by proceeds from the disposal of Robinhood shares, and the transaction is expected to impact the company’s investment portfolio by increasing its stake in TeraWulf, a digital asset technology company.

Brainhole Technology Limited Announces Major Disposal of Robinhood Shares
Oct 12, 2025

Brainhole Technology Limited has announced a major transaction involving the further disposal of 12,700 Robinhood Shares, generating approximately US$1.9 million. This transaction, when aggregated with previous disposals, constitutes a major transaction under the Hong Kong Listing Rules, requiring shareholder approval, which has been obtained from Yoho Bravo Limited, holding a significant majority of the company’s shares. No extraordinary general meeting will be convened as a result.

Brainhole Technology Limited Announces Key Securities Transactions
Sep 11, 2025

Brainhole Technology Limited has announced two significant transactions involving the acquisition and disposal of listed securities. On September 11, 2025, the company acquired 119,500 TeraWulf shares for approximately US$1.3 million and disposed of 14,400 Tempus shares for approximately US$1.2 million. Both transactions are classified as discloseable under the Hong Kong Listing Rules, as they exceed the 5% threshold but remain below 25%, necessitating public announcement and reporting.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 19, 2025